Bio-Techne Corp
TECH65.850USD
+2.360+3.72%
收盘 11/25, 16:00（美东）报价延迟15分钟
10.26B总市值
131.57市盈率 TTM
关于 Bio-Techne Corp 公司
Bio-Techne Corporation 是一家全球生命科学公司，为研究和临床诊断界提供工具和生物活性试剂。该公司的产品有助于对生物过程以及特定疾病的性质和进展进行科学研究。该公司与 Wilson Wolf 合作，正在开发专门针对 G-Rex 生物反应器的产品，例如培养基和细胞因子。其部门包括蛋白质科学和诊断与基因组学。蛋白质科学部门是生命科学研究、诊断和细胞及基因治疗各个方面所用生物试剂的开发商和制造商。该部门还包括手动和自动蛋白质组学分析工具。诊断与基因组学部门开发和制造诊断产品，包括用于受监管诊断市场的控制品、校准器和诊断检测、基于外泌体的分子诊断检测和组织活检分析。
Bio-Techne Corp简介
公司代码TECH
公司名称Bio-Techne Corp
上市日期Feb 09, 1989
CEOMr. Kim Kelderman
员工数量3100
证券类型Ordinary Share
年结日Feb 09
公司地址614 Mckinley Pl N E
城市MINNEAPOLIS
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编55413
电话16123792956
网址https://www.bio-techne.com/
公司代码TECH
上市日期Feb 09, 1989
CEOMr. Kim Kelderman
Bio-Techne Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.51%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-4.52%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.66%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+11.91%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+17.55%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+22.99%
Dr. Matthew F. Mcmanus
Dr. Matthew F. Mcmanus
President - Diagnostics and Spatial Biology
President - Diagnostics and Spatial Biology
4.74K
+169.49%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
4.38K
--
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+76.56%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.51%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-4.52%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.66%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+11.91%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+17.55%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+22.99%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumables
972.29M
79.72%
Instruments
112.09M
9.19%
Service
111.57M
9.15%
Royalty
23.69M
1.94%
地区USD
名称
营收
占比
United States
683.23M
56.02%
EMEA, excluding U.K
266.31M
21.83%
Greater China
100.46M
8.24%
APAC, excluding Greater China
77.26M
6.33%
United Kingdom
54.83M
4.50%
Rest of World
37.55M
3.08%
业务
地区
业务USD
名称
营收
占比
Consumables
972.29M
79.72%
Instruments
112.09M
9.19%
Service
111.57M
9.15%
Royalty
23.69M
1.94%
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
其他
72.73%
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
其他
72.73%
股东类型
持股股东
占比
Investment Advisor
57.86%
Investment Advisor/Hedge Fund
34.00%
Hedge Fund
8.05%
Bank and Trust
2.18%
Research Firm
1.96%
Pension Fund
1.33%
Sovereign Wealth Fund
1.24%
Individual Investor
0.28%
Insurance Company
0.24%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1198
161.18M
103.53%
-7.34M
2025Q2
1209
165.25M
105.41%
-730.33K
2025Q1
1245
168.10M
107.22%
+1.54M
2024Q4
1233
162.21M
102.61%
-6.39M
2024Q3
1205
159.40M
100.49%
-10.21M
2024Q2
1207
160.52M
101.86%
-12.24M
2024Q1
1216
162.56M
103.40%
-7.57M
2023Q4
1229
159.70M
100.98%
-3.97M
2023Q3
1217
156.41M
98.84%
-7.93M
2023Q2
1213
155.36M
98.68%
-4.04M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
18.40M
11.82%
-60.83K
-0.33%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.79M
5.65%
-512.26K
-5.50%
Jun 30, 2025
State Street Investment Management (US)
5.86M
3.76%
-671.30K
-10.28%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
4.29M
2.76%
+573.23K
+15.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.06M
2.61%
-30.89K
-0.75%
Jun 30, 2025
Invesco Capital Management LLC
3.24M
2.08%
+274.96K
+9.28%
Jun 30, 2025
Neuberger Berman, LLC
2.50M
1.61%
-526.06K
-17.38%
Jun 30, 2025
T. Rowe Price Associates, Inc.
8.62M
5.53%
-2.53M
-22.68%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Global X Genomics & Biotechnology ETF
3.95%
Invesco Biotechnology & Genome ETF
2.62%
Invesco S&P 500 Equal Weight Health Care ETF
1.79%
VanEck Biotech ETF
1.63%
Neuberger Berman Small-Mid Cap ETF
1.58%
Hilton Small-MidCap Opportunity ETF
1.55%
Thrivent Small-Mid Cap ESG ETF
1.44%
American Century Mid Cap Growth Impact ETF
1.39%
WisdomTree BioRevolution Fund
1.22%
iShares Health Innovation Active ETF
1.2%
查看更多
Global X Genomics & Biotechnology ETF
占比3.95%
Invesco Biotechnology & Genome ETF
占比2.62%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.79%
VanEck Biotech ETF
占比1.63%
Neuberger Berman Small-Mid Cap ETF
占比1.58%
Hilton Small-MidCap Opportunity ETF
占比1.55%
Thrivent Small-Mid Cap ESG ETF
占比1.44%
American Century Mid Cap Growth Impact ETF
占比1.39%
WisdomTree BioRevolution Fund
占比1.22%
iShares Health Innovation Active ETF
占比1.2%
分红派息
近5年累计派现
250.90M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 05, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 17, 2025
Feb 28, 2025
Feb 14, 2025
Oct 30, 2024
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024
Nov 11, 2024
Nov 22, 2024
Nov 08, 2024
Aug 07, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024
Aug 19, 2024
Aug 30, 2024
Aug 19, 2024
May 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024
May 13, 2024
May 24, 2024
May 10, 2024
Feb 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 26, 2024
Feb 09, 2024
Oct 31, 2023
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023
Nov 10, 2023
Nov 24, 2023
Nov 09, 2023
Aug 08, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 01, 2023
Aug 17, 2023
May 03, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023
May 15, 2023
May 26, 2023
May 12, 2023
Feb 02, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023
Feb 13, 2023
Feb 27, 2023
Feb 10, 2023
Nov 01, 2022
TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
查看更多
拆合股
公告日期
类型
比率
Nov 01, 2022
Split
1→4
公告日期
类型
比率
Nov 01, 2022
Split
1→4
常见问题
Bio-Techne Corp的前五大股东是谁？
Bio-Techne Corp 的前五大股东如下：
The Vanguard Group, Inc.持有股份：18.40M，占总股份比例：11.82%。
BlackRock Institutional Trust Company, N.A.持有股份：8.79M，占总股份比例：5.65%。
State Street Investment Management (US)持有股份：5.86M，占总股份比例：3.76%。
Atlanta Capital Management Company, L.L.C.持有股份：4.29M，占总股份比例：2.76%。
Geode Capital Management, L.L.C.持有股份：4.06M，占总股份比例：2.61%。
The Vanguard Group, Inc.持有股份：18.40M，占总股份比例：11.82%。
BlackRock Institutional Trust Company, N.A.持有股份：8.79M，占总股份比例：5.65%。
State Street Investment Management (US)持有股份：5.86M，占总股份比例：3.76%。
Atlanta Capital Management Company, L.L.C.持有股份：4.29M，占总股份比例：2.76%。
Geode Capital Management, L.L.C.持有股份：4.06M，占总股份比例：2.61%。
Bio-Techne Corp的前三大股东类型是什么？
Bio-Techne Corp 的前三大股东类型分别是：
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
有多少机构持有Bio-Techne Corp(TECH)的股份？
截至2025Q3，共有1198家机构持有Bio-Techne Corp的股份，合计持有的股份价值约为161.18M，占公司总股份的103.53%。与2025Q2相比，机构持股有所增加，增幅为-1.88%。
哪个业务部门对Bio-Techne Corp的收入贡献最大？
在FY2025，Consumables业务部门对Bio-Techne Corp的收入贡献最大，创收972.29M，占总收入的79.72%。
